Literature DB >> 10942075

Antioxidant adaptive response of human mononuclear cells to UV-B: effect of lipoic acid.

S Alvarez1, A Boveris.   

Abstract

Supplementation of human mononuclear cells with 3 and 6 mM of lipoic acid produces an inhibition of the antioxidant adaptive response triggered by treatment with UV-B light (0.30 W/m2 for 15 min). Supplementation with 1.5 mM of lipoic acid gives no conclusive results. The adaptive response is characterized by an increase in the activities of superoxide dismutase, catalase, glutathione peroxidase and DT-diaphorase. Catalase (5.5 +/- 0.6 pmol/mg prot) increases its activity by up to 22 +/- 3 pmol/mg prot, after irradiation with UV-B. Supplementation with 3 and 6 mM of lipoic acid completely inhibits the adaptive response. The activities of the membrane-bound mitochondrial enzymes succinate dehydrogenase and cytochrome oxidase do not increase after UV-B exposure. Moreover, their activities are found to decrease and the addition of lipoic acid does not prevent this effect. The inhibition of the antioxidant response by lipoic acid in human cells appears as indirect evidence of the existence of oxidative stress in the development of this response. As lipoic acid behaves as an effective antioxidant, it seems that its action decreases the intracellular oxidative signals necessary to develop the adaptive response in human mononuclear cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942075     DOI: 10.1016/s1011-1344(00)00030-0

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  2 in total

1.  The Degradation and Regeneration of alpha-Lipoic Acid under the Irradiation of UV Light in the Existence of Homocysteine.

Authors:  Naoki Wada; Hirotaka Wakami; Tetsuya Konishi; Seiichi Matsugo
Journal:  J Clin Biochem Nutr       Date:  2009-04-25       Impact factor: 3.114

2.  Cell‑specific and roasting‑dependent regulation of the Keap1/Nrf2 pathway by coffee extracts.

Authors:  Alexandros Priftis; Antonia-Eugenia Angeli-Terzidou; Aristidis S Veskoukis; Demetrios A Spandidos; Dimitrios Kouretas
Journal:  Mol Med Rep       Date:  2018-04-24       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.